Replantation Surgery: Are we progressing or regressing?

Read the article on CBS News

Tyler Theroux came into the world with a brachial plexus birth injury that kept his left arm dysfunctional and contorted in pain. As a child, he couldn’t engage in playground activities like the monkey bars, and his classmates would bully him about the injury.

Eventually, Theroux dropped out of school to be homeschooled. While the teasing stopped, the pain didn’t: His parents watched him experience fresh agony with every growth spurt. The brachial plexus is the group of nerves that sends signals from the spinal cord to the shoulder, arm and hand, and that nerve pain kept him awake at night, despite multiple attempts at surgery and therapeutic treatment.

graph of success rate of replantation

What does the results say?

The decades that followed, however, showed a stable field lacking any significant changes or advancements. More recently, and especially in the United States, the frequency with which surgeons even attempt replantation and the rate of survival have plummeted. If this trend continues, successful replantation surgery will become all too rare of an event. It is critical that we evaluate the state of replantation surgery today, identify the primary causes, and work to not only revive the field but allow it to advance similar to other areas of medicine.

This is an abstract of an article published on www.parjournal.net by Dr Jacques Hacquebord and Karen Noh.

Read the full article here

Related Articles

From inspiring patients to thorough research, our blog is for doctors seeking answers and information.

Redefining the Management of Fuchs Dystrophy

Since its introduction in the United States in the mid-2010s, Descemet stripping only (DSO) has revolutionized the surgical management of Fuchs dystrophy. Although similar procedures were originally explored in the 1950s and for some time after, these met with little success.

The current technique—pioneered in the United States by Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor of Ophthalmology and chair of the Department of Ophthalmology at NYU Grossman School of Medicine—involves removal of the diseased endothelium and mound-shaped aggregates, known as guttae, without the need for a donor graft.

NYU Langone Convenes World’s Experts on Bionic Reconstruction

From early on in his career, Jacques Hacquebord, MD, performed major reconstructive work on patients at NYC Health +
Hospitals/Bellevue, including many with hand and arm amputations. Caring for these patients introduced him to the fascinating
world of prosthetic devices. Working with occupational therapists, mental health experts, and those who make and fit artificial
limbs, known as prosthetists, he saw a field brimming with potential.